Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Computed Tomography Angiography | 50 | 2023 | 424 | 6.120 |
Why?
|
Coronary Artery Disease | 36 | 2022 | 696 | 4.950 |
Why?
|
Contrast Media | 46 | 2022 | 594 | 4.740 |
Why?
|
Magnetic Resonance Angiography | 17 | 2021 | 181 | 4.480 |
Why?
|
Coronary Angiography | 50 | 2023 | 866 | 4.110 |
Why?
|
Magnetic Resonance Imaging | 31 | 2022 | 2222 | 3.930 |
Why?
|
Tomography, X-Ray Computed | 53 | 2023 | 2323 | 3.360 |
Why?
|
Peripheral Arterial Disease | 6 | 2021 | 83 | 3.030 |
Why?
|
Coronary Stenosis | 19 | 2023 | 246 | 3.030 |
Why?
|
Heart | 15 | 2022 | 850 | 2.920 |
Why?
|
Fractional Flow Reserve, Myocardial | 14 | 2022 | 137 | 2.760 |
Why?
|
Transcatheter Aortic Valve Replacement | 11 | 2022 | 90 | 2.730 |
Why?
|
Myocardial Infarction | 14 | 2020 | 807 | 2.570 |
Why?
|
Vascular Calcification | 13 | 2020 | 131 | 2.550 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 27 | 2022 | 373 | 2.470 |
Why?
|
Gadolinium | 9 | 2022 | 88 | 2.280 |
Why?
|
Magnetic Resonance Imaging, Cine | 17 | 2023 | 83 | 2.160 |
Why?
|
Coronary Vessels | 19 | 2020 | 313 | 1.980 |
Why?
|
Myocardium | 18 | 2022 | 1204 | 1.940 |
Why?
|
Aortic Valve Stenosis | 10 | 2022 | 177 | 1.900 |
Why?
|
Reproducibility of Results | 37 | 2021 | 2077 | 1.800 |
Why?
|
Predictive Value of Tests | 34 | 2022 | 1465 | 1.710 |
Why?
|
Myocardial Perfusion Imaging | 10 | 2021 | 100 | 1.430 |
Why?
|
Aortography | 3 | 2021 | 72 | 1.380 |
Why?
|
Humans | 138 | 2023 | 68525 | 1.370 |
Why?
|
Aorta, Thoracic | 2 | 2021 | 211 | 1.290 |
Why?
|
Organometallic Compounds | 5 | 2022 | 95 | 1.250 |
Why?
|
Retrospective Studies | 56 | 2023 | 7264 | 1.210 |
Why?
|
Algorithms | 22 | 2022 | 1194 | 1.210 |
Why?
|
Male | 97 | 2023 | 37281 | 1.210 |
Why?
|
Artificial Intelligence | 10 | 2023 | 159 | 1.190 |
Why?
|
Myocardial Ischemia | 4 | 2021 | 172 | 1.180 |
Why?
|
Myocarditis | 3 | 2020 | 49 | 1.170 |
Why?
|
Angiography, Digital Subtraction | 6 | 2020 | 63 | 1.160 |
Why?
|
Female | 90 | 2023 | 38015 | 1.160 |
Why?
|
Prospective Studies | 22 | 2022 | 3702 | 1.130 |
Why?
|
Aged | 57 | 2023 | 14842 | 1.110 |
Why?
|
Machine Learning | 8 | 2022 | 170 | 1.100 |
Why?
|
Image Processing, Computer-Assisted | 14 | 2021 | 689 | 1.090 |
Why?
|
Diagnostic Imaging | 4 | 2021 | 201 | 1.070 |
Why?
|
Middle Aged | 65 | 2023 | 21119 | 1.050 |
Why?
|
Preoperative Care | 4 | 2021 | 275 | 1.050 |
Why?
|
Lower Extremity | 6 | 2020 | 153 | 1.040 |
Why?
|
Aortic Valve | 8 | 2022 | 249 | 1.040 |
Why?
|
Plaque, Atherosclerotic | 8 | 2022 | 125 | 1.000 |
Why?
|
Imaging, Three-Dimensional | 7 | 2019 | 333 | 0.980 |
Why?
|
Heart Diseases | 4 | 2022 | 276 | 0.980 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 10 | 2019 | 91 | 0.970 |
Why?
|
Respiration | 4 | 2019 | 91 | 0.930 |
Why?
|
Gadolinium DTPA | 7 | 2015 | 48 | 0.880 |
Why?
|
Image Enhancement | 4 | 2021 | 143 | 0.880 |
Why?
|
Sensitivity and Specificity | 22 | 2021 | 1753 | 0.870 |
Why?
|
Heart Neoplasms | 2 | 2020 | 33 | 0.860 |
Why?
|
Arterial Occlusive Diseases | 2 | 2019 | 134 | 0.830 |
Why?
|
Constriction, Pathologic | 7 | 2023 | 236 | 0.820 |
Why?
|
Heart Atria | 5 | 2022 | 206 | 0.770 |
Why?
|
Aorta, Abdominal | 2 | 2021 | 97 | 0.750 |
Why?
|
Severity of Illness Index | 17 | 2022 | 1851 | 0.750 |
Why?
|
Abdomen | 2 | 2019 | 80 | 0.740 |
Why?
|
Feasibility Studies | 9 | 2021 | 652 | 0.730 |
Why?
|
Thoracic Neoplasms | 1 | 2020 | 10 | 0.730 |
Why?
|
Pelvis | 1 | 2019 | 38 | 0.720 |
Why?
|
Radiation Dosage | 17 | 2022 | 419 | 0.700 |
Why?
|
Thorax | 2 | 2023 | 49 | 0.700 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2021 | 134 | 0.700 |
Why?
|
Cardiomyopathies | 4 | 2023 | 167 | 0.680 |
Why?
|
Image Interpretation, Computer-Assisted | 5 | 2021 | 237 | 0.680 |
Why?
|
Medical Oncology | 1 | 2020 | 110 | 0.670 |
Why?
|
Phantoms, Imaging | 7 | 2023 | 189 | 0.670 |
Why?
|
Four-Dimensional Computed Tomography | 1 | 2018 | 6 | 0.660 |
Why?
|
Aortic Diseases | 1 | 2019 | 113 | 0.650 |
Why?
|
Magnetic Resonance Spectroscopy | 7 | 2023 | 346 | 0.630 |
Why?
|
Stents | 5 | 2022 | 657 | 0.600 |
Why?
|
Aged, 80 and over | 16 | 2022 | 4843 | 0.580 |
Why?
|
Observer Variation | 8 | 2018 | 330 | 0.570 |
Why?
|
Heart Ventricles | 7 | 2022 | 738 | 0.570 |
Why?
|
Nerve Net | 4 | 2021 | 180 | 0.550 |
Why?
|
Meglumine | 1 | 2015 | 16 | 0.540 |
Why?
|
Coronary Circulation | 2 | 2015 | 136 | 0.530 |
Why?
|
Adult | 35 | 2022 | 21375 | 0.530 |
Why?
|
Sarcoma, Ewing | 1 | 2015 | 26 | 0.530 |
Why?
|
Iohexol | 6 | 2018 | 82 | 0.530 |
Why?
|
Coronary Thrombosis | 1 | 2015 | 45 | 0.530 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2022 | 756 | 0.530 |
Why?
|
Calcinosis | 4 | 2018 | 241 | 0.520 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2015 | 277 | 0.510 |
Why?
|
Diagnosis, Computer-Assisted | 3 | 2019 | 75 | 0.500 |
Why?
|
Apolipoprotein E4 | 3 | 2021 | 31 | 0.500 |
Why?
|
Electrocardiography | 6 | 2022 | 601 | 0.500 |
Why?
|
Eosinophilia | 1 | 2014 | 47 | 0.500 |
Why?
|
Calcium | 6 | 2022 | 929 | 0.500 |
Why?
|
Heart Aneurysm | 1 | 2014 | 21 | 0.500 |
Why?
|
Aspergillosis | 1 | 2014 | 20 | 0.500 |
Why?
|
Stroke Volume | 7 | 2023 | 586 | 0.500 |
Why?
|
Prognosis | 12 | 2023 | 2093 | 0.480 |
Why?
|
Percutaneous Coronary Intervention | 3 | 2022 | 137 | 0.460 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2014 | 116 | 0.460 |
Why?
|
Ventricular Function, Left | 8 | 2023 | 481 | 0.450 |
Why?
|
Fabry Disease | 2 | 2022 | 6 | 0.440 |
Why?
|
Artifacts | 5 | 2019 | 125 | 0.440 |
Why?
|
Heart Defects, Congenital | 4 | 2019 | 596 | 0.430 |
Why?
|
Signal-To-Noise Ratio | 7 | 2021 | 93 | 0.420 |
Why?
|
Young Adult | 13 | 2021 | 5708 | 0.380 |
Why?
|
Time Factors | 10 | 2021 | 4655 | 0.370 |
Why?
|
Dilatation, Pathologic | 2 | 2021 | 58 | 0.370 |
Why?
|
Polymers | 1 | 2012 | 244 | 0.370 |
Why?
|
Radiographic Image Enhancement | 5 | 2018 | 208 | 0.370 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2022 | 164 | 0.350 |
Why?
|
Cardiac Imaging Techniques | 2 | 2021 | 35 | 0.350 |
Why?
|
Pulmonary Emphysema | 2 | 2020 | 71 | 0.350 |
Why?
|
Swine | 5 | 2015 | 672 | 0.350 |
Why?
|
Echocardiography | 4 | 2022 | 515 | 0.340 |
Why?
|
Defibrillators, Implantable | 2 | 2023 | 329 | 0.330 |
Why?
|
Heart Failure | 3 | 2023 | 1179 | 0.320 |
Why?
|
ROC Curve | 9 | 2019 | 392 | 0.320 |
Why?
|
Multimodal Imaging | 3 | 2022 | 62 | 0.320 |
Why?
|
Adolescent | 11 | 2021 | 8903 | 0.310 |
Why?
|
Multidetector Computed Tomography | 2 | 2019 | 60 | 0.310 |
Why?
|
Presenilin-2 | 2 | 2017 | 6 | 0.310 |
Why?
|
Lung Diseases | 2 | 2020 | 175 | 0.310 |
Why?
|
Presenilin-1 | 2 | 2017 | 28 | 0.310 |
Why?
|
Kidney Transplantation | 3 | 2022 | 839 | 0.300 |
Why?
|
Disease Models, Animal | 7 | 2019 | 2550 | 0.300 |
Why?
|
Endovascular Procedures | 2 | 2021 | 366 | 0.290 |
Why?
|
Radiography, Abdominal | 2 | 2017 | 57 | 0.280 |
Why?
|
Lung Neoplasms | 1 | 2015 | 1172 | 0.280 |
Why?
|
Hippocampus | 2 | 2021 | 471 | 0.270 |
Why?
|
Acute Coronary Syndrome | 2 | 2017 | 195 | 0.260 |
Why?
|
Cardiac-Gated Imaging Techniques | 4 | 2019 | 60 | 0.250 |
Why?
|
Liver Diseases | 2 | 2016 | 193 | 0.250 |
Why?
|
Kidney Failure, Chronic | 2 | 2017 | 365 | 0.230 |
Why?
|
Risk Factors | 7 | 2023 | 5719 | 0.230 |
Why?
|
Fibrosis | 4 | 2022 | 371 | 0.230 |
Why?
|
Risk Assessment | 6 | 2021 | 2004 | 0.230 |
Why?
|
Staining and Labeling | 2 | 2014 | 144 | 0.230 |
Why?
|
Tin | 3 | 2018 | 16 | 0.230 |
Why?
|
Brain | 4 | 2017 | 2175 | 0.220 |
Why?
|
Bone Diseases, Metabolic | 1 | 2023 | 30 | 0.220 |
Why?
|
Radiography, Thoracic | 2 | 2020 | 99 | 0.220 |
Why?
|
Workflow | 2 | 2020 | 100 | 0.220 |
Why?
|
Osteoporosis | 1 | 2023 | 88 | 0.210 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2023 | 117 | 0.210 |
Why?
|
Iodine | 2 | 2019 | 41 | 0.200 |
Why?
|
Angiography | 2 | 2021 | 194 | 0.200 |
Why?
|
Fractures, Compression | 1 | 2021 | 11 | 0.200 |
Why?
|
Heart Valve Diseases | 1 | 2022 | 123 | 0.200 |
Why?
|
Reference Values | 1 | 2022 | 579 | 0.200 |
Why?
|
Hematoma | 1 | 2021 | 47 | 0.200 |
Why?
|
Anthracyclines | 1 | 2020 | 9 | 0.200 |
Why?
|
Neuropsychological Tests | 6 | 2021 | 517 | 0.200 |
Why?
|
Endoleak | 1 | 2021 | 23 | 0.190 |
Why?
|
Spinal Fractures | 1 | 2021 | 43 | 0.190 |
Why?
|
Injections | 3 | 2020 | 119 | 0.190 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2021 | 106 | 0.190 |
Why?
|
Pentetic Acid | 3 | 2016 | 18 | 0.190 |
Why?
|
Body Mass Index | 4 | 2016 | 866 | 0.190 |
Why?
|
Respiratory Function Tests | 1 | 2020 | 123 | 0.180 |
Why?
|
Radiology | 1 | 2021 | 97 | 0.180 |
Why?
|
Atrial Fibrillation | 1 | 2022 | 248 | 0.180 |
Why?
|
Treatment Outcome | 6 | 2022 | 7028 | 0.180 |
Why?
|
Blood Flow Velocity | 2 | 2017 | 172 | 0.180 |
Why?
|
Connectome | 1 | 2021 | 91 | 0.180 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2021 | 139 | 0.180 |
Why?
|
Animals | 11 | 2020 | 20877 | 0.170 |
Why?
|
Mitral Valve | 1 | 2020 | 166 | 0.170 |
Why?
|
Child | 5 | 2022 | 6400 | 0.170 |
Why?
|
Aorta | 2 | 2021 | 316 | 0.170 |
Why?
|
Tetrazolium Salts | 3 | 2015 | 36 | 0.170 |
Why?
|
Obesity | 2 | 2016 | 1074 | 0.170 |
Why?
|
Coronary Vessel Anomalies | 1 | 2019 | 45 | 0.160 |
Why?
|
Anticoagulants | 1 | 2021 | 356 | 0.160 |
Why?
|
Renal Artery Obstruction | 1 | 2018 | 29 | 0.160 |
Why?
|
Movement | 1 | 2019 | 179 | 0.160 |
Why?
|
Smokers | 1 | 2020 | 198 | 0.160 |
Why?
|
Doxorubicin | 1 | 2019 | 231 | 0.150 |
Why?
|
Dogs | 5 | 2020 | 490 | 0.150 |
Why?
|
Disease Progression | 1 | 2021 | 1037 | 0.150 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 207 | 0.150 |
Why?
|
Diagnosis, Differential | 4 | 2014 | 1139 | 0.150 |
Why?
|
Angina, Stable | 1 | 2016 | 13 | 0.150 |
Why?
|
Radiation Exposure | 4 | 2019 | 84 | 0.150 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2017 | 115 | 0.150 |
Why?
|
Regional Blood Flow | 1 | 2017 | 168 | 0.150 |
Why?
|
Area Under Curve | 4 | 2019 | 238 | 0.140 |
Why?
|
Vascular Diseases | 1 | 2017 | 94 | 0.140 |
Why?
|
Hemangiosarcoma | 1 | 2016 | 23 | 0.140 |
Why?
|
Coronary Restenosis | 1 | 2016 | 42 | 0.140 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 161 | 0.140 |
Why?
|
Magnetic Fields | 1 | 2016 | 21 | 0.140 |
Why?
|
Graft Occlusion, Vascular | 1 | 2016 | 73 | 0.140 |
Why?
|
Irritable Bowel Syndrome | 1 | 2015 | 10 | 0.140 |
Why?
|
Follow-Up Studies | 5 | 2021 | 3256 | 0.140 |
Why?
|
Amyloid beta-Peptides | 1 | 2017 | 190 | 0.130 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 546 | 0.130 |
Why?
|
Apolipoproteins E | 1 | 2015 | 92 | 0.130 |
Why?
|
Lung | 4 | 2022 | 849 | 0.130 |
Why?
|
Autopsy | 1 | 2014 | 56 | 0.130 |
Why?
|
Mutation | 2 | 2017 | 1213 | 0.130 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2015 | 100 | 0.130 |
Why?
|
Fatal Outcome | 1 | 2014 | 164 | 0.130 |
Why?
|
Chronic Disease | 2 | 2018 | 1329 | 0.120 |
Why?
|
Cognition Disorders | 1 | 2017 | 342 | 0.120 |
Why?
|
Amygdala | 1 | 2016 | 159 | 0.120 |
Why?
|
Emotions | 1 | 2016 | 244 | 0.120 |
Why?
|
Analysis of Variance | 1 | 2017 | 1039 | 0.120 |
Why?
|
Blood Vessel Prosthesis | 1 | 2015 | 182 | 0.120 |
Why?
|
Necrosis | 1 | 2014 | 239 | 0.120 |
Why?
|
Liver | 2 | 2018 | 1118 | 0.120 |
Why?
|
Decision Making | 1 | 2017 | 410 | 0.120 |
Why?
|
Cerebrovascular Circulation | 1 | 2015 | 296 | 0.120 |
Why?
|
Liver Neoplasms | 1 | 2018 | 334 | 0.120 |
Why?
|
Software | 3 | 2022 | 418 | 0.120 |
Why?
|
Case-Control Studies | 4 | 2019 | 1548 | 0.120 |
Why?
|
Cognition | 1 | 2017 | 512 | 0.120 |
Why?
|
Hemodynamics | 1 | 2016 | 705 | 0.110 |
Why?
|
Random Allocation | 1 | 2014 | 442 | 0.110 |
Why?
|
Biopsy | 1 | 2014 | 539 | 0.110 |
Why?
|
Microspheres | 1 | 2012 | 59 | 0.110 |
Why?
|
Coloring Agents | 1 | 2012 | 66 | 0.110 |
Why?
|
In Vitro Techniques | 1 | 2012 | 765 | 0.100 |
Why?
|
Adipose Tissue | 2 | 2022 | 221 | 0.090 |
Why?
|
Arrhythmias, Cardiac | 1 | 2012 | 239 | 0.090 |
Why?
|
Postoperative Complications | 1 | 2018 | 1615 | 0.090 |
Why?
|
Brain Mapping | 3 | 2017 | 531 | 0.090 |
Why?
|
Heterozygote | 2 | 2021 | 174 | 0.080 |
Why?
|
Depression | 1 | 2016 | 942 | 0.080 |
Why?
|
Rest | 2 | 2019 | 78 | 0.080 |
Why?
|
Heart Rate | 2 | 2023 | 568 | 0.080 |
Why?
|
Ischemia | 2 | 2022 | 229 | 0.080 |
Why?
|
Filtration | 2 | 2018 | 61 | 0.080 |
Why?
|
Aneurysm, False | 1 | 2007 | 60 | 0.080 |
Why?
|
Registries | 2 | 2021 | 730 | 0.070 |
Why?
|
Cardiac Catheterization | 2 | 2022 | 419 | 0.070 |
Why?
|
Germany | 2 | 2016 | 67 | 0.070 |
Why?
|
Adenosine | 2 | 2016 | 165 | 0.070 |
Why?
|
Survival Rate | 2 | 2019 | 1055 | 0.070 |
Why?
|
Vasodilator Agents | 2 | 2016 | 138 | 0.060 |
Why?
|
Myocardial Reperfusion | 2 | 2015 | 32 | 0.060 |
Why?
|
Absorptiometry, Photon | 1 | 2023 | 83 | 0.060 |
Why?
|
Tomography | 1 | 2022 | 9 | 0.050 |
Why?
|
Hypertrophy | 1 | 2022 | 89 | 0.050 |
Why?
|
Ventricular Function, Right | 1 | 2023 | 103 | 0.050 |
Why?
|
Lumbar Vertebrae | 1 | 2023 | 112 | 0.050 |
Why?
|
Bone Density | 1 | 2023 | 159 | 0.050 |
Why?
|
Radiologists | 1 | 2022 | 35 | 0.050 |
Why?
|
Morbidity | 1 | 2022 | 130 | 0.050 |
Why?
|
Purines | 1 | 2021 | 39 | 0.050 |
Why?
|
Infant | 2 | 2019 | 2891 | 0.050 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2021 | 137 | 0.050 |
Why?
|
X-Ray Microtomography | 1 | 2021 | 50 | 0.050 |
Why?
|
Acceleration | 1 | 2021 | 37 | 0.050 |
Why?
|
Child, Preschool | 2 | 2019 | 3185 | 0.050 |
Why?
|
Muscles | 1 | 2021 | 158 | 0.050 |
Why?
|
Inpatients | 1 | 2022 | 208 | 0.050 |
Why?
|
Pyrazoles | 1 | 2021 | 190 | 0.050 |
Why?
|
Time | 1 | 2020 | 57 | 0.050 |
Why?
|
Pattern Recognition, Automated | 1 | 2020 | 70 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2021 | 160 | 0.050 |
Why?
|
Chest Pain | 1 | 2021 | 151 | 0.050 |
Why?
|
Automation | 1 | 2019 | 45 | 0.040 |
Why?
|
Cerebral Hemorrhage | 1 | 2021 | 198 | 0.040 |
Why?
|
Asia | 1 | 2019 | 59 | 0.040 |
Why?
|
North America | 1 | 2019 | 111 | 0.040 |
Why?
|
Sphingolipids | 1 | 2022 | 337 | 0.040 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2021 | 185 | 0.040 |
Why?
|
Europe | 1 | 2019 | 195 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2019 | 82 | 0.040 |
Why?
|
Recurrence | 1 | 2021 | 948 | 0.040 |
Why?
|
Carbon Dioxide | 1 | 2018 | 78 | 0.040 |
Why?
|
Renal Artery | 1 | 2018 | 29 | 0.040 |
Why?
|
Injections, Intra-Arterial | 1 | 2017 | 30 | 0.040 |
Why?
|
Carotid Stenosis | 1 | 2019 | 163 | 0.040 |
Why?
|
Efferent Pathways | 1 | 2017 | 15 | 0.040 |
Why?
|
Arteries | 1 | 2018 | 108 | 0.040 |
Why?
|
Auditory Pathways | 1 | 2017 | 20 | 0.040 |
Why?
|
Visual Pathways | 1 | 2017 | 31 | 0.040 |
Why?
|
Phenotype | 1 | 2021 | 946 | 0.040 |
Why?
|
Exercise Test | 1 | 2019 | 242 | 0.040 |
Why?
|
Apolipoprotein E2 | 1 | 2017 | 8 | 0.040 |
Why?
|
Mental Status and Dementia Tests | 1 | 2017 | 9 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2021 | 1054 | 0.040 |
Why?
|
Isolated Heart Preparation | 1 | 2017 | 8 | 0.040 |
Why?
|
Pulmonary Artery | 1 | 2019 | 323 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2021 | 445 | 0.040 |
Why?
|
Breath Holding | 1 | 2016 | 8 | 0.040 |
Why?
|
Forecasting | 1 | 2018 | 277 | 0.040 |
Why?
|
Sus scrofa | 1 | 2017 | 74 | 0.040 |
Why?
|
Hepatic Artery | 1 | 2016 | 25 | 0.040 |
Why?
|
Portal Vein | 1 | 2016 | 46 | 0.040 |
Why?
|
Arterial Pressure | 1 | 2017 | 46 | 0.040 |
Why?
|
Triiodobenzoic Acids | 1 | 2016 | 28 | 0.040 |
Why?
|
Auditory Perception | 1 | 2017 | 89 | 0.040 |
Why?
|
Reference Standards | 1 | 2016 | 115 | 0.040 |
Why?
|
Executive Function | 1 | 2017 | 106 | 0.040 |
Why?
|
Hematemesis | 1 | 2016 | 14 | 0.040 |
Why?
|
Visual Perception | 1 | 2017 | 124 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 2264 | 0.040 |
Why?
|
Patient Care Planning | 1 | 2016 | 108 | 0.040 |
Why?
|
Hemoptysis | 1 | 2016 | 28 | 0.040 |
Why?
|
Models, Cardiovascular | 1 | 2017 | 133 | 0.040 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2016 | 52 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 503 | 0.030 |
Why?
|
United States | 2 | 2019 | 7335 | 0.030 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2015 | 5 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2017 | 230 | 0.030 |
Why?
|
Hospitalization | 1 | 2021 | 977 | 0.030 |
Why?
|
Attention | 1 | 2017 | 225 | 0.030 |
Why?
|
Aortic Aneurysm | 1 | 2016 | 77 | 0.030 |
Why?
|
Organ Size | 1 | 2015 | 242 | 0.030 |
Why?
|
Healthy Volunteers | 1 | 2015 | 78 | 0.030 |
Why?
|
Neural Pathways | 1 | 2017 | 323 | 0.030 |
Why?
|
Body Temperature | 1 | 2015 | 116 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2015 | 219 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2016 | 174 | 0.030 |
Why?
|
Demography | 1 | 2015 | 279 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 567 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2015 | 301 | 0.030 |
Why?
|
Motor Activity | 1 | 2017 | 621 | 0.030 |
Why?
|
Recovery of Function | 1 | 2017 | 506 | 0.030 |
Why?
|
Odds Ratio | 1 | 2016 | 880 | 0.030 |
Why?
|
Inflammation | 1 | 2020 | 1030 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 785 | 0.030 |
Why?
|
Ultrasonography | 1 | 2015 | 453 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2016 | 1046 | 0.030 |
Why?
|
Electroencephalography | 1 | 2015 | 418 | 0.030 |
Why?
|
Logistic Models | 1 | 2016 | 1419 | 0.030 |
Why?
|
Alzheimer Disease | 1 | 2017 | 563 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 938 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2017 | 2453 | 0.030 |
Why?
|
Reperfusion | 1 | 2011 | 78 | 0.020 |
Why?
|
Angioplasty, Balloon | 1 | 2011 | 110 | 0.020 |
Why?
|
South Carolina | 1 | 2016 | 2750 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 1660 | 0.020 |
Why?
|
Models, Statistical | 1 | 2011 | 446 | 0.020 |
Why?
|